GT199900027A - Composiciones farmacèuticas que contienen en asociaciòn un antagonista selectivo de los receptores v1adelaarginina-vasopresina y un antogonista selectivo de los receptores v2 de la arginina-vasopresina. - Google Patents

Composiciones farmacèuticas que contienen en asociaciòn un antagonista selectivo de los receptores v1adelaarginina-vasopresina y un antogonista selectivo de los receptores v2 de la arginina-vasopresina.

Info

Publication number
GT199900027A
GT199900027A GT199900027A GT199900027A GT199900027A GT 199900027 A GT199900027 A GT 199900027A GT 199900027 A GT199900027 A GT 199900027A GT 199900027 A GT199900027 A GT 199900027A GT 199900027 A GT199900027 A GT 199900027A
Authority
GT
Guatemala
Prior art keywords
receptors
selective antagonist
association
pharmaceutical compositions
compositions containing
Prior art date
Application number
GT199900027A
Other languages
English (en)
Inventor
Collette Lacour
Dino Nisato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900027A publication Critical patent/GT199900027A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÒN SE REFIERE A COMPOSICIONES FARMACÈUTICAS QUE CONTIENEN EN ASOCIACIÒN EL (2S)1(2R, 3S)5CLORO3(2CLOROFENIL)1(3,4DIMETOXI BENCENO SULFONIL3HIDROXI2,3DIHIDRO1HINDOL2CARBONIL)PIRROLIDINA2CARBOXAMIDA, ANTAGONISTA SELECTIVO DE LOS RECEPTORES V1A DE LA ARGININAVASOPRESINA, CON EL 1(4(NTERBUTILCARBAMOIL)2METOXIBENCENOSULFONIL) 5ETOXI3ESPIRO(4(2MOFOLINOETILOXI)CICLOHEXANOL)INDOL2ONA, LAS ESTRUCTURAS ESTÀN DESARROLLADAS EN LA PARTE INFERIOR, ISÒMERO ECUATORIAL, O UNA DE SUS SALES, ANTAGONISTA SELECTIVO DE LOS RECEPTORES V2 DE LA ARGININA VASOPRESINA.
GT199900027A 1998-03-06 1999-02-26 Composiciones farmacèuticas que contienen en asociaciòn un antagonista selectivo de los receptores v1adelaarginina-vasopresina y un antogonista selectivo de los receptores v2 de la arginina-vasopresina. GT199900027A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9802874A FR2775598A1 (fr) 1998-03-06 1998-03-06 Compositions pharmaceutiques contenant en association un antagoniste selectif des recepteurs v1a de l'arginine-vasopressine et un antagoniste selectif des recepteur v2 de l'arginine-vasopressine

Publications (1)

Publication Number Publication Date
GT199900027A true GT199900027A (es) 2000-08-19

Family

ID=9523839

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900027A GT199900027A (es) 1998-03-06 1999-02-26 Composiciones farmacèuticas que contienen en asociaciòn un antagonista selectivo de los receptores v1adelaarginina-vasopresina y un antogonista selectivo de los receptores v2 de la arginina-vasopresina.

Country Status (10)

Country Link
US (1) US6627649B1 (es)
EP (1) EP1063996A1 (es)
JP (1) JP2002505289A (es)
AR (1) AR016984A1 (es)
AU (1) AU2629299A (es)
CO (1) CO5070635A1 (es)
FR (1) FR2775598A1 (es)
GT (1) GT199900027A (es)
WO (1) WO1999044613A1 (es)
ZA (1) ZA991765B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792834A1 (fr) * 1999-04-29 2000-11-03 Sanofi Sa Utilisation du sr 49059, de ses solvats et/ou hydrates pharmaceutiquement acceptables, pour la preparation de medicaments utiles dans le traitement ou la prevention du phenomene de raynaud
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
PL1750862T3 (pl) 2004-06-04 2011-06-30 Teva Pharma Kompozycja farmaceutyczna zawierająca irbesartan
US8445461B2 (en) 2007-01-10 2013-05-21 Setsuko Takeda Pharmaceutical composition for meniere's disease
WO2010042714A1 (en) * 2008-10-10 2010-04-15 Janssen Pharmaceutica Nv Combination therapy comprising angiotensin receptor blockers and vasopressin receptor antagonists
WO2019141575A1 (de) 2018-01-16 2019-07-25 Bayer Aktiengesellschaft Unterstützung bei der behandlung von herzinsuffizienz

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
US5338755A (en) 1990-07-31 1994-08-16 Elf Sanofi N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
FR2740136B1 (fr) 1995-10-24 1998-01-09 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
JP2002505289A (ja) 2002-02-19
FR2775598A1 (fr) 1999-09-10
CO5070635A1 (es) 2001-08-28
AU2629299A (en) 1999-09-20
EP1063996A1 (fr) 2001-01-03
AR016984A1 (es) 2001-08-01
US6627649B1 (en) 2003-09-30
WO1999044613A1 (fr) 1999-09-10
ZA991765B (en) 1999-09-06

Similar Documents

Publication Publication Date Title
PT747050E (pt) Composicoes farmaceuticas que contem irbesartan
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
BR0109943A (pt) Composições farmacêuticas
ES2195355T3 (es) Formulado farmaceutico que contiene voriconazol.
PT981375E (pt) Composicoes farmaceuticas contendo proteinas do plasma
ES2191183T3 (es) Derivados 6,6- o 6,7-biciclicos que contienen pirido o pirimido sustituidos.
CY1106366T1 (el) Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου
DE69912983D1 (de) Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel
ES2186887T3 (es) Comprimidos que contienen una mezcla adulcorante.
FR2732592B1 (fr) Compositions cosmetiques autobronzantes
CY1106633T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιεχουν χαλκο, σαλικυλικο οξυ και βιταμινη c
GT199900027A (es) Composiciones farmacèuticas que contienen en asociaciòn un antagonista selectivo de los receptores v1adelaarginina-vasopresina y un antogonista selectivo de los receptores v2 de la arginina-vasopresina.
PA8577701A1 (es) Polipeptido t20 pegilado
DE69702544D1 (de) D,L-Weinsäure enthaltende, gaserzeugende Zusammensetzungen
NO963526D0 (no) N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)-etylÅ-2,2-difenylacetamid
BR0015198A (pt) Combinação de dispositivo e embalagem de coloração de dente, e, matriz
DE60117594D1 (de) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
ES2156616T3 (es) (r)-5-bromo-n-(1-etil-4-metilhexahidro-1h-1,4-diazepan-6-il)-2-metoxi-6-metilamino-3-piridincarboxamida, procedimiento para su produccion y composicion medicinal que la contiene.
PT952975E (pt) Compostos bi-aromaticos ligados por um radical hetero-etinileno e composicoes farmaceuticas e cosmeticas que os contem
BR9808915A (pt) Moduladores da função dos receptores da famìlia de receptores fnt/fgn
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
PT1041966E (pt) Composicoes farmaceuticas que compreendem zafirlukast
ES2182090T3 (es) Nuevos derivados de pirrol.
FI943069A0 (fi) Kloorittomia, mahdollisesti vetypitoisia fluorihiilivetyjä sisältävät koostumukset
BRPI0401916A (pt) Preparações que contêm compostos de amÈnio quaternários e tensìdios aniÈnicos